Joseph Damond, Chair of Health Policy, guides clients through the global healthcare industry, leveraging a government relations career focused on healthcare, trade and innovation.

Prior to joining EGA, Mr. Damond served as deputy chief policy officer and executive vice president for International Affairs at the Biotechnology Innovation Organization (BIO) where he developed the industry association’s global policy strategy on healthcare, economic and trade issues, and foreign government relations policy. Before his work at BIO, Mr. Damond served as vice president for International Government Relations for Pfizer where he managed their international trade and commercial issues, including leading industry efforts to strengthen market access and intellectual property (IP) provisions in the U.S.-Korea Free Trade Agreement. Prior to Pfizer, he worked as deputy vice president for International Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA) where he led Asia and global market access programs, and developed the industry’s successful strategy for market IP and access provisions in the U.S.-Australia Free Trade Agreement.

Mr. Damond spent more than 10 years as an Assistant U.S. Trade Representative for Asia and the Pacific, serving in several capacities, including Special Economic Assistant to the U.S. Trade Representative (USTR), Executive Director of the Generalized System of Preferences, and Deputy in the USTR’s Asia office.

Mr. Damond studied at Princeton and Georgetown universities, and authored the book, Give Trade a Chance: The Negotiation of the U.S.-Vietnam Bilateral Trade Agreement.


Joseph Damond

Chair, Health Policy